HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.

AbstractBACKGROUND:
Dutch people born between 1925 and 1945 were ineligible for vaccination with the inactivated poliovirus vaccine (IPV) introduced in 1957 and may have escaped natural infection because of reduced poliovirus circulation. We examined whether people with low or undetectable antibody levels are susceptible to infection and whether memory immunity provides protection against virus excretion.
METHODS:
A total of 429 elderly participants were challenged with monovalent oral poliovirus vaccine (type 1 or 3) and followed for 8 weeks. Immune responses and virus excretion were compared for 4 groups, defined on the basis of seronegativity for poliovirus type 1 or 3, natural immunity, and IPV-induced immunity.
RESULTS:
On the basis of the rapidity of the antibody response and the absence of immunoglobulin M, we saw clear evidence of memory immune responses in 33% of the participants without detectable antibodies against poliovirus type 1 and in 5% of the participants without detectable antibodies against poliovirus type 3. Fecal virus-excretion patterns were not significantly different for seronegative participants, regardless of whether they showed evidence of memory immunity.
CONCLUSIONS:
Rapid antibody responses after challenge with oral polio vaccine provide evidence for poliovirus-specific memory immunity in seronegative elderly people. However, in contrast to preexisting immunity, memory immunity does not protect against virus excretion. These results have important implications for the poliomyelitis-eradication initiative, in particular for future immunization policies after eradication has been achieved.
AuthorsFrithjofna Abbink, Anne M Buisman, Gerda Doornbos, Jan Woldman, Tjeerd G Kimman, Marina A E Conyn-van Spaendonck
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 191 Issue 6 Pg. 990-9 (Mar 15 2005) ISSN: 0022-1899 [Print] United States
PMID15717277 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin M
  • Poliovirus Vaccine, Inactivated
  • Poliovirus Vaccine, Oral
Topics
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral (blood)
  • Feces (virology)
  • Humans
  • Immunoglobulin M (blood)
  • Immunologic Memory
  • Netherlands
  • Neutralization Tests
  • Poliomyelitis (immunology, prevention & control)
  • Poliovirus (immunology)
  • Poliovirus Vaccine, Inactivated (administration & dosage, immunology)
  • Poliovirus Vaccine, Oral (administration & dosage, immunology)
  • Vaccination
  • Virus Shedding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: